WJPR Citation Report New

  All Since 2021
 Citation  9186  4781
 h-index  32  25
 i10-index  256  108

Submit Article

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

COMMUNITY-BASED INTEGRATIVE CARE FOR CORONAVIRUS DISEASE: POSITIONING HOMOEOPATHY WITHIN PUBLIC HEALTH

Dr. Don J. Scott Berin G. MD(Hom)*, Dr. Judith Rajendran MD (Community Medicine), Prof. Dr. Raena R., M.D. (Hom.), Dr. V. J. Beautlin Previncy BHMS, MBA (HOSP. Mngt) MD (Hom)

Abstract

Background: SARS-CoV-2-caused coronavirus illness (COVID-19) revealed worldwide public health issues and highlighted robust healthcare systems. Prevention, rehabilitation, and comprehensive patient-centered treatment may be enhanced by evidence-based integrative methods, such as Homoeopathy within regulated TCIM frameworks. Objective: To examine how Homoeopathy may fit within a community medicine framework for Covid-19 and to provide an evidence-based integrative public health practice approach. Methods: The literature on COVID-19 epidemiology, community-based healthcare, integrative medicine, clinical trials pertaining to Homoeopathy, and evidence-based clinical therapy is included in this narrative review. A retrospective observational research, randomised controlled trials, systematic reviews, and pertinent international guidelines are all included in the review. Results: Health education, immunisation, surveillance, early detection of decline, continuity of treatment, and referral all benefit from community-based initiatives. The conclusions that may be derived from published Homoeopathy-related COVID-19 research are limited by methodological constraints, study outcome variability, and the requirement for independent replication. These studies include randomised trials and observational reports. A retrospective review of 367 patients revealed improvement in 73.8% of instances; however, these results cannot be attributed to Homoeopathic treatment because there is no control group. Homoeopathy as a supplement to conventional therapy was also examined in a 2023 randomised experiment.

Keywords: Community Medicine; Coronavirus Disease; COVID-19; Homoeopathy; Integrative Healthcare; Primary Health Care; Public Health; Rehabilitation; SARS-CoV-2.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More